| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0264-410X(98)00466-6 |
| P698 | PubMed publication ID | 10403598 |
| P2093 | author name string | J Wright | |
| M Cochran | |||
| J K Collins | |||
| D N Reddy | |||
| J Norris | |||
| E B Belknap | |||
| V K Ayers | |||
| L M Walters | |||
| C Hayhow | |||
| C Kelling | |||
| J McMillen | |||
| P2860 | cites work | A conventionally attenuated glycoprotein E-negative strain of bovine herpesvirus type 1 is an efficacious and safe vaccine | Q34329758 |
| Rapid detection of bovine herpesvirus type 1 antigens in nasal swab specimens with an antigen capture enzyme-linked immunosorbent assay. | Q37277614 | ||
| Cloning and cleavage site mapping of DNA from bovine herpesvirus 1 (Cooper strain) | Q40137693 | ||
| Rapid, sensitive, competitive serologic enzyme-linked immunosorbent assay for detecting serum antibodies to bovine herpesvirus type 1. | Q40209851 | ||
| Molecular virology of ruminant herpesviruses | Q40661473 | ||
| An attenuated bovine herpesvirus 1 marker vaccine induces a better protection than two inactivated marker vaccines | Q40662753 | ||
| Bovine herpesvirus-1 vaccines | Q40795544 | ||
| Pathogenesis of ruminant herpesvirus infections | Q40921092 | ||
| Novel viral vaccines for livestock | Q40921278 | ||
| Protective immunity in cattle following vaccination with conventional and marker bovine herpesvirus-1 (BHV1) vaccines | Q41141342 | ||
| Advances in the development and evaluation of bovine herpesvirus 1 vaccines | Q41332602 | ||
| Cell-specific kinetics and efficiency of herpes simplex virus type 1 entry are determined by two distinct phases of attachment | Q41489513 | ||
| Truncated bovine herpesvirus-1 glycoprotein I (gpI) initiates a protective local immune response in its natural host | Q41491018 | ||
| Identification of 108K, 93K, and 42K glycoproteins of bovine herpesvirus-1 by monoclonal antibodies | Q41585041 | ||
| Bovine herpesvirus-1 (infectious bovine rhinotracheitis virus)-based viral vector which expresses foot-and-mouth disease epitopes | Q41672232 | ||
| Antigenic differences between the major glycoproteins of bovine herpesvirus type 1.1 and bovine encephalitis herpesvirus type 1.3 | Q44494041 | ||
| An in vivo study of a glycoprotein gIII-negative bovine herpesvirus 1 (BHV-1) mutant expressing beta-galactosidase: evaluation of the role of gIII in virus infectivity and its use as a vector for mucosal immunization | Q44592119 | ||
| Virulence and immunogenicity in calves of thymidine kinase- and glycoprotein E-negative bovine herpesvirus 1 mutants | Q44821297 | ||
| Protection of cattle from BHV-1 infection by immunization with recombinant glycoprotein gIV. | Q52545266 | ||
| Mucosal and systemic immunity to bovine herpesvirus-1 glycoprotein D confer resistance to viral replication and latency in cattle | Q71568305 | ||
| Epitope-specific antibody responses in market-stressed calves to bovine herpesvirus type 1 | Q71658934 | ||
| An inactivated vaccine based on a glycoprotein E-negative strain of bovine herpesvirus 1 induces protective immunity and allows serological differentiation | Q72339888 | ||
| Efficacy of a deletion mutant bovine herpesvirus-1 (BHV-1) vaccine that allows serologic differentiation of vaccinated from naturally infected animals | Q72720034 | ||
| Study of immunogenicity and virulence of bovine herpesvirus 1 mutants deficient in the UL49 homolog, UL49.5 homolog and dUTPase genes in cattle | Q73619647 | ||
| Immunization of cattle with a BHV1 vector vaccine or a DNA vaccine both coding for the G protein of BRSV | Q73978906 | ||
| P433 | issue | 18 | |
| P304 | page(s) | 2297-2305 | |
| P577 | publication date | 1999-05-01 | |
| P1433 | published in | Vaccine | Q7907941 |
| P1476 | title | Immunogenicity and protective efficacy of a gE, gG and US2 gene-deleted bovine herpesvirus-1 (BHV-1) vaccine | |
| P478 | volume | 17 |
| Q61807875 | Antibody Responses to Bovine Alphaherpesvirus 1 (BoHV-1) in Passively Immunized Calves |
| Q39465632 | Attenuation of bovine herpesvirus type 1 by deletion of its glycoprotein G and tk genes and protection against virulent viral challenge |
| Q27480923 | Current Status of Veterinary Vaccines |
| Q38116993 | Immunity to bovine herpesvirus 1: II. Adaptive immunity and vaccinology |
| Q64899453 | Mapping a highly conserved linear neutralizing epitope on gD glycoprotein of bovine herpesvirus type I using a monoclonal antibody. |
| Q33228903 | Pro and contra IBR-eradication |
| Q37497064 | Protection induced by a glycoprotein E-deleted bovine herpesvirus type 1 marker strain used either as an inactivated or live attenuated vaccine in cattle. |
| Q36305113 | Recent developments in veterinary vaccinology |
| Q41221653 | Virus, strain, and epitope specificities of neutralizing bovine monoclonal antibodies to bovine herpesvirus 1 glycoproteins gB, gC, and gD, with sequence and molecular model analysis |
Search more.